Developer docs
API playgroundTry for free, no card

Search company profiles

InfuCare Rx

Full company profile

uuid0007br7

Namestring
InfuCare Rx
Legal namestring
InfuCare Rx, Inc.
Websiteurl
infucarerx.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

InfuCare Rx is a nationwide specialty infusion therapy pharmacy services provider headquartered in Fairfield, New Jersey, serving more than 14,000 patients with complex and chronic conditions across all 50 U.S. states. The company operates a portfolio of six core therapy programs — Anti-Infective Therapy, Bleeding Disorders (Hemophilia), Chronic Inflammatory conditions, Immunoglobulin (IG) Therapy, Parenteral Nutrition, and Specialty Injectables — delivered through therapy-specialized Centers of Excellence located in Aston, PA; Cumberland, MD; Pine Brook, NJ; Kenner, LA; Pottsville, PA; and additional pharmacy, infusion suite, and infusion nursing office sites across approximately a dozen states. Care is delivered via three principal modalities: home infusion, company-operated infusion suites, and ambulatory sites, supported by 24/7 clinical staffing, benefit verification, prior authorization support, and reimbursement assistance.

The company's digital infrastructure centers on the InfuCare Rx Health® platform, a proprietary care management system delivered via online portal and mobile app, providing digital prescriptions, secure communication, and patient management functionality to patients, prescribers, and partners. The platform also powers payor-facing dashboards with therapy-specific outcomes reporting (hemophilia, neurology, immunology) and value-based metrics across 30,000+ annual infusions. InfuCare Rx holds URAC and ACHC accreditations across multiple states and four ACHC program types (Infusion Pharmacy, Specialty Pharmacy, Home Infusion Therapy, Ambulatory Infusion Center).

The business model is B2B2C: InfuCare Rx acquires patients through healthcare provider referrals, prescriber networks, health system partnerships, and payor/managed care contracts, then delivers reimbursed pharmacy and clinical services billed to insurance carriers, Medicare, and other payors. Revenue is generated through per-therapy reimbursement for both drug costs and clinical management services, supplemented by financial counseling and copay assistance. The company was founded in 2014, received strategic investment from One Equity Partners in January 2022, acquired Health First Infusion (Florida) in November 2022, completed an OEP-led founder buyback and Guggenheim Investments recapitalization in November 2025, and added the Tendo Marketplace as an employer-channel distribution partner in April 2026.

Short descriptiontext

InfuCare Rx is a nationwide specialty infusion therapy pharmacy provider serving over 14,000 patients across all 50 states with complex chronic conditions. It operates therapy-specialized Centers of Excellence in hemophilia, IG therapy, and specialty infusion, supported by the InfuCare Rx Health® digital platform and reimbursed through payor contracts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersFairfield, United States
HQ citystring
Fairfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices26 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty infusion therapy, home infusion services, specialty pharmacy services, immunoglobulin therapy, infusion care management
Industry3 codes
PRIMARYHLADAFAG
Home Infusion Therapy & IV Nursing Services
Healthcare & Life Sciences/Elder Care & Long-Term Care/Home Health Care Services (Skilled)
SECONDARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFAEAE
Home Infusion Therapy Providers
NAICS code2 codes
  • Home Health Care Services621610
  • Ambulatory Health Care Services621
SIC code1 code
  • Services-Home Health Care Services8082
Product category
Specialty Infusion Therapy Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Specialty Infusion Therapy Services
TypeManaged Services
Description

InfuCare Rx generates revenue by providing specialty infusion therapy services to patients with complex conditions. Services include anti-infective therapy, bleeding disorders treatment, chronic inflammatory conditions, immunoglobulin therapy, parenteral nutrition, and specialty injectables. Revenue is derived from reimbursement from health insurance, Medicare, and other payors for pharmacy and clinical services provided.

infucarerx.com
2Clinical Therapy Management
TypeProfessional Services
Description

The company provides comprehensive clinical therapy management services through its data-driven Centers of Excellence. Revenue is generated through reimbursement for clinical assessment, patient monitoring, medication reconciliation, and ongoing therapy compliance support services.

infucarerx.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Specialty Infusion Therapy Services - Quote-based pricing through insurance verification
ModelSubscriptionBilling cadenceMonthly
Notes

Services are billed through insurance with benefit verification and prior authorization support provided. Copay assistance and financial counseling available for patients.

infucarerx.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1InfuCare Rx Health
Description

Digital care management platform that delivers personalized digital medicine to patients, prescribers, and partners through an online portal and mobile app, offering digital prescriptions, secure communication, and patient management features.

infucarerx.com
Core offering1 text field

InfuCare Rx is a nationwide specialty pharmacy infusion therapy services provider that delivers clinical infusion care to patients with complex and chronic conditions. Its core offerings span six therapy areas — anti-infective therapy, bleeding disorders, chronic inflammatory therapy, immunoglobulin (IVIG/SCIG) therapy, parenteral nutrition, and specialty injectables — administered through company-operated Centers of Excellence, infusion suites, and home-based infusion nursing. These clinical services are supported by InfuCare Rx Health®, a proprietary digital care management platform with patient portal, mobile app, digital prescriptions, and secure communication, alongside enrollment, benefit verification, prior authorization, and 24/7 clinical support services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 30,000+ annual infusions managed with clinical oversight
+1 more record
Product overview1 text field

InfuCare Rx is a nationwide specialty pharmacy infusion therapy services provider offering a portfolio of six core specialty infusion therapy services: Anti-Infective Therapy, Bleeding Disorders Therapy, Chronic Inflammatory Therapy, Immunoglobulin (IG) Therapy, Parenteral Nutrition, and Specialty Injectables. The company operates alongside its digital care management platform, InfuCare Rx Health®, which provides patients, prescribers, and partners with digital prescriptions, secure communication, and patient management capabilities through an online portal and mobile app. The core services are delivered through a network of Centers of Excellence specializing in different therapy areas (specialty infusion/acute therapy, hemophilia/bleeding disorders, IG therapy, and nursing care management) located across multiple states, with the company serving over 14,000 patients across all 50 states.

Product and service7 records
1Anti-Infective Therapy
CategorySpecialty Infusion Therapy Service
Description

Specialty infusion therapy service providing intravenous administration of antibiotic, antiviral, or anti-fungal drugs for infectious diseases that do not respond to oral medications. Delivered via home infusion, infusion suites, and clinical management for patients with complex infectious disease needs.

2Bleeding Disorders Therapy
CategorySpecialty Infusion Therapy Service
Description

Specialized hemophilia and bleeding disorders therapy program providing comprehensive care for conditions including Hemophilia A, Hemophilia B, Von Willebrand Disease, and rare factor deficiencies, with clinical management and home-based factor infusion support.

3Chronic Inflammatory Therapy
CategorySpecialty Infusion Therapy Service
Description

Infusion therapy services for chronic inflammatory conditions including Ankylosing Spondylitis, Crohn's Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, and other autoimmune disorders, delivered via home infusion and infusion suites.

4Immunoglobulin (IG) Therapy
CategorySpecialty Infusion Therapy Service
Description

Immunoglobulin therapy services including both intravenous (IVIG) and subcutaneous (SCIG) administration for treatment of primary immunodeficiency diseases and autoimmune conditions, with clinical management and home-based or suite-based administration.

5Parenteral Nutrition
CategorySpecialty Infusion Therapy Service
Description

Intravenous nutrition therapy providing protein, carbohydrate, fat, minerals, electrolytes, vitamins, and trace elements for patients who cannot eat or absorb enough food to maintain good nutrition status, with compounding and home infusion support.

6Specialty Injectables
CategorySpecialty Infusion Therapy Service
Description

Specialty injectable drug therapies for treatment of chronic and/or life-threatening conditions requiring administration by injection, infusion, or inhalation, with monitoring and educational counseling.

7InfuCare Rx Health® Digital Care Management Platform
CategoryDigital Health Platform
Description

Digital care management platform providing a complete infusion care ecosystem through an online portal and mobile app. Delivers personalized digital medicine including digital prescriptions, secure communication, and patient management capabilities for patients, prescribers, and partners, with data-driven outcomes dashboards for payors.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-04-01
Description

Tendo announced an agreement with InfuCare Rx in April 2026 to expand access to high-quality, cost-effective infusion care nationwide through the Tendo Marketplace. InfuCare Rx joined as a national infusion care provider, offering access to employers and health plan members through Tendo's digital health platform.

2Health First Infusion
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-11-01
Description

InfuCare Rx acquired the business assets of Health First Infusion (HFI), a Florida-based home infusion pharmacy, in November 2022. The acquisition expanded InfuCare Rx's regional presence in Florida and supported its mission of providing high-quality, cost-effective home infusion services.

infucarerx.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Regional home infusion and specialty respiratory pharmacy provider serving the Northeast and Mid-Atlantic. Overlaps with InfuCare Rx's strong Northeast footprint (NJ, PA, MD) and specialty infusion service lines.

TypeDirect peer
Description

Specialty infusion provider offering home infusion, enteral/parenteral nutrition, and specialty pharmacy services across multiple states. Competes with InfuCare Rx in home-based complex-condition infusion.

TypeRegional player
Description

Specialty home infusion provider concentrated in the Southeast (South Carolina, Georgia) with focus on chronic inflammatory, IG, and anti-infective therapies. Regional peer comparable on therapy mix though not geography.

TypeEmerging player
Description

Specialty pharmacy focused on rare and orphan disease therapies including enzyme replacement and hemophilia products. Adjacent competitor in the limited-distribution specialty pharmacy channel that overlaps with InfuCare Rx's bleeding disorders and IG franchises.

TypeDirect peer
Description

Specialty home infusion company with deep expertise in immune globulin (IG) therapy and bleeding disorders. Directly comparable to InfuCare Rx on therapy-area focus, particularly IG and hemophilia Centers of Excellence.

TypeDirect peer
Description

Specialty infusion and home infusion provider focused on complex conditions including IG therapy, hemophilia, chronic inflammatory disease, and anti-infectives. Closely matches InfuCare Rx's Centers of Excellence therapy mix and mid-size national positioning.

TypeBroad incumbent
Description

Specialty pharmacy and infusion services operated by UnitedHealth Group's Optum, integrating payor (UnitedHealthcare), PBM (OptumRx), and dispensing capabilities. Represents the integrated-payor model InfuCare Rx competes against for payor contracts and drug access.

TypeBroad incumbent
Description

PBM-owned specialty pharmacy arm of Express Scripts/Evernorth, providing specialty drug distribution and clinical management for complex therapies including IG and hemophilia. A vertically integrated competitor and payor counterpart that InfuCare Rx must work around.

TypeDirect peer
Description

The specialty infusion arm of CVS Health, providing home infusion, enteral nutrition, and specialty pharmacy services nationwide. Competes directly with InfuCare Rx but operates with the structural advantage of PBM/care integration via CVS Caremark.

TypeDirect peer
Description

The largest independent provider of home and alternate-site infusion services in the United States, serving patients with complex conditions across a broad therapy portfolio. Most direct comparable to InfuCare Rx by service mix, scale ambitions, and payor contracting model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InfuCare Rx

Specialty Infusion Therapy Servicesinfucarerx.com

InfuCare Rx is a nationwide specialty infusion therapy pharmacy provider serving over 14,000 patients across all 50 states with complex chronic conditions. It operates therapy-specialized Centers of Excellence in hemophilia, IG therapy, and specialty infusion, supported by the InfuCare Rx Health® digital platform and reimbursed through payor contracts.

What InfuCare Rx does

InfuCare Rx is a nationwide specialty infusion therapy pharmacy services provider headquartered in Fairfield, New Jersey, serving more than 14,000 patients with complex and chronic conditions across all 50 U.S. states. The company operates a portfolio of six core therapy programs — Anti-Infective Therapy, Bleeding Disorders (Hemophilia), Chronic Inflammatory conditions, Immunoglobulin (IG) Therapy, Parenteral Nutrition, and Specialty Injectables — delivered through therapy-specialized Centers of Excellence located in Aston, PA; Cumberland, MD; Pine Brook, NJ; Kenner, LA; Pottsville, PA; and additional pharmacy, infusion suite, and infusion nursing office sites across approximately a dozen states. Care is delivered via three principal modalities: home infusion, company-operated infusion suites, and ambulatory sites, supported by 24/7 clinical staffing, benefit verification, prior authorization support, and reimbursement assistance.

The company's digital infrastructure centers on the InfuCare Rx Health® platform, a proprietary care management system delivered via online portal and mobile app, providing digital prescriptions, secure communication, and patient management functionality to patients, prescribers, and partners. The platform also powers payor-facing dashboards with therapy-specific outcomes reporting (hemophilia, neurology, immunology) and value-based metrics across 30,000+ annual infusions. InfuCare Rx holds URAC and ACHC accreditations across multiple states and four ACHC program types (Infusion Pharmacy, Specialty Pharmacy, Home Infusion Therapy, Ambulatory Infusion Center).

The business model is B2B2C: InfuCare Rx acquires patients through healthcare provider referrals, prescriber networks, health system partnerships, and payor/managed care contracts, then delivers reimbursed pharmacy and clinical services billed to insurance carriers, Medicare, and other payors. Revenue is generated through per-therapy reimbursement for both drug costs and clinical management services, supplemented by financial counseling and copay assistance. The company was founded in 2014, received strategic investment from One Equity Partners in January 2022, acquired Health First Infusion (Florida) in November 2022, completed an OEP-led founder buyback and Guggenheim Investments recapitalization in November 2025, and added the Tendo Marketplace as an employer-channel distribution partner in April 2026.

InfuCare Rx firmographics

Firmographics
Name
InfuCare Rx
Legal name
InfuCare Rx, Inc.
Website
https://infucarerx.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
251–500 employees
Short description
InfuCare Rx is a nationwide specialty infusion therapy pharmacy provider serving over 14,000 patients across all 50 states with complex chronic conditions. It operates therapy-specialized Centers of Excellence in hemophilia, IG therapy, and specialty infusion, supported by the InfuCare Rx Health® digital platform and reimbursed through payor contracts.
Ownership category
akta.pro rank

InfuCare Rx industry classification

Industry
Product category
Specialty Infusion Therapy Services
NAICS
Home Health Care Services (621610), Ambulatory Health Care Services (621)
SIC
Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLADAFAG
Home Infusion Therapy & IV Nursing Services
Healthcare & Life Sciences/Elder Care & Long-Term Care/Home Health Care Services (Skilled)
SECONDARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFAEAE
Home Infusion Therapy Providers

Keywords

  • Specialty infusion therapy
  • Home infusion services
  • Specialty pharmacy services
  • Immunoglobulin therapy
  • Infusion care management

Where InfuCare Rx is headquartered

Location

Headquarters

HQ city
Fairfield
HQ country
United States
HQ region
North America

Offices26 records

Markets served

InfuCare Rx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Specialty Infusion Therapy Services: InfuCare Rx generates revenue by providing specialty infusion therapy services to patients with complex conditions. Services include anti-infective therapy, bleeding disorders treatment, chronic inflammatory conditions, immunoglobulin therapy, parenteral nutrition, and specialty injectables. Revenue is derived from reimbursement from health insurance, Medicare, and other payors for pharmacy and clinical services provided.
  2. Clinical Therapy Management: The company provides comprehensive clinical therapy management services through its data-driven Centers of Excellence. Revenue is generated through reimbursement for clinical assessment, patient monitoring, medication reconciliation, and ongoing therapy compliance support services.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlySpecialty Infusion Therapy Services - Quote-based pricing through insurance verification

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

InfuCare Rx product offering

Product offering

Core offering

InfuCare Rx is a nationwide specialty pharmacy infusion therapy services provider that delivers clinical infusion care to patients with complex and chronic conditions. Its core offerings span six therapy areas — anti-infective therapy, bleeding disorders, chronic inflammatory therapy, immunoglobulin (IVIG/SCIG) therapy, parenteral nutrition, and specialty injectables — administered through company-operated Centers of Excellence, infusion suites, and home-based infusion nursing. These clinical services are supported by InfuCare Rx Health®, a proprietary digital care management platform with patient portal, mobile app, digital prescriptions, and secure communication, alongside enrollment, benefit verification, prior authorization, and 24/7 clinical support services.

Product overview

InfuCare Rx is a nationwide specialty pharmacy infusion therapy services provider offering a portfolio of six core specialty infusion therapy services: Anti-Infective Therapy, Bleeding Disorders Therapy, Chronic Inflammatory Therapy, Immunoglobulin (IG) Therapy, Parenteral Nutrition, and Specialty Injectables. The company operates alongside its digital care management platform, InfuCare Rx Health®, which provides patients, prescribers, and partners with digital prescriptions, secure communication, and patient management capabilities through an online portal and mobile app. The core services are delivered through a network of Centers of Excellence specializing in different therapy areas (specialty infusion/acute therapy, hemophilia/bleeding disorders, IG therapy, and nursing care management) located across multiple states, with the company serving over 14,000 patients across all 50 states.

Differentiator

Problem solved

Functional benefit

Brands

  • InfuCare Rx Health: Digital care management platform that delivers personalized digital medicine to patients, prescribers, and partners through an online portal and mobile app, offering digital prescriptions, secure communication, and patient management features.

Products and services

  • Anti-Infective Therapy Specialty infusion therapy service providing intravenous administration of antibiotic, antiviral, or anti-fungal drugs for infectious diseases that do not respond to oral medications. Delivered via home infusion, infusion suites, and clinical management for patients with complex infectious disease needs.
  • Bleeding Disorders Therapy Specialized hemophilia and bleeding disorders therapy program providing comprehensive care for conditions including Hemophilia A, Hemophilia B, Von Willebrand Disease, and rare factor deficiencies, with clinical management and home-based factor infusion support.
  • Chronic Inflammatory Therapy Infusion therapy services for chronic inflammatory conditions including Ankylosing Spondylitis, Crohn's Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, and other autoimmune disorders, delivered via home infusion and infusion suites.
  • Immunoglobulin (IG) Therapy Immunoglobulin therapy services including both intravenous (IVIG) and subcutaneous (SCIG) administration for treatment of primary immunodeficiency diseases and autoimmune conditions, with clinical management and home-based or suite-based administration.
  • Parenteral Nutrition Intravenous nutrition therapy providing protein, carbohydrate, fat, minerals, electrolytes, vitamins, and trace elements for patients who cannot eat or absorb enough food to maintain good nutrition status, with compounding and home infusion support.
  • Specialty Injectables Specialty injectable drug therapies for treatment of chronic and/or life-threatening conditions requiring administration by injection, infusion, or inhalation, with monitoring and educational counseling.
  • InfuCare Rx Health® Digital Care Management Platform Digital care management platform providing a complete infusion care ecosystem through an online portal and mobile app. Delivers personalized digital medicine including digital prescriptions, secure communication, and patient management capabilities for patients, prescribers, and partners, with data-driven outcomes dashboards for payors.

Quantifiable outcome

  • 30,000+ annual infusions managed with clinical oversight
  • +1 more outcomes

Companies that use InfuCare Rx

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

InfuCare Rx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

InfuCare Rx partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • TendocoreGTM or Marketing Partner · 1 April 2026Tendo announced an agreement with InfuCare Rx in April 2026 to expand access to high-quality, cost-effective infusion care nationwide through the Tendo Marketplace. InfuCare Rx joined as a national infusion care provider, offering access to employers and health plan members through Tendo's digital health platform.
  • Health First InfusionminorStrategic or Co-development Partner · 1 November 2022InfuCare Rx acquired the business assets of Health First Infusion (HFI), a Florida-based home infusion pharmacy, in November 2022. The acquisition expanded InfuCare Rx's regional presence in Florida and supported its mission of providing high-quality, cost-effective home infusion services.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

InfuCare Rx competitors and assessment

Company assessment

Direct peers

  • PromptCare: Regional home infusion and specialty respiratory pharmacy provider serving the Northeast and Mid-Atlantic. Overlaps with InfuCare Rx's strong Northeast footprint (NJ, PA, MD) and specialty infusion service lines.
  • Amerita (formerly AmeritaRx): Specialty infusion provider offering home infusion, enteral/parenteral nutrition, and specialty pharmacy services across multiple states. Competes with InfuCare Rx in home-based complex-condition infusion.
  • KabaFusion: Specialty home infusion company with deep expertise in immune globulin (IG) therapy and bleeding disorders. Directly comparable to InfuCare Rx on therapy-area focus, particularly IG and hemophilia Centers of Excellence.
  • Soleo Health: Specialty infusion and home infusion provider focused on complex conditions including IG therapy, hemophilia, chronic inflammatory disease, and anti-infectives. Closely matches InfuCare Rx's Centers of Excellence therapy mix and mid-size national positioning.
  • Coram CVS (CVS Health Infusion Services): The specialty infusion arm of CVS Health, providing home infusion, enteral nutrition, and specialty pharmacy services nationwide. Competes directly with InfuCare Rx but operates with the structural advantage of PBM/care integration via CVS Caremark.
  • Option Care Health: The largest independent provider of home and alternate-site infusion services in the United States, serving patients with complex conditions across a broad therapy portfolio. Most direct comparable to InfuCare Rx by service mix, scale ambitions, and payor contracting model.

Regional players

  • Intramed Plus: Specialty home infusion provider concentrated in the Southeast (South Carolina, Georgia) with focus on chronic inflammatory, IG, and anti-infective therapies. Regional peer comparable on therapy mix though not geography.

Emerging players

  • PantherRx Rare: Specialty pharmacy focused on rare and orphan disease therapies including enzyme replacement and hemophilia products. Adjacent competitor in the limited-distribution specialty pharmacy channel that overlaps with InfuCare Rx's bleeding disorders and IG franchises.

Broad incumbents

  • Optum Specialty / OptumRx Infusion: Specialty pharmacy and infusion services operated by UnitedHealth Group's Optum, integrating payor (UnitedHealthcare), PBM (OptumRx), and dispensing capabilities. Represents the integrated-payor model InfuCare Rx competes against for payor contracts and drug access.
  • Accredo (Express Scripts / Evernorth): PBM-owned specialty pharmacy arm of Express Scripts/Evernorth, providing specialty drug distribution and clinical management for complex therapies including IG and hemophilia. A vertically integrated competitor and payor counterpart that InfuCare Rx must work around.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

InfuCare Rx social profiles

Digital presence

InfuCare Rx compliance and trust

Trust signal

Compliance2 records

InfuCare Rx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InfuCare Rx leadership team

Management profile

Number of profiles

InfuCare Rx subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

InfuCare Rx funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InfuCare Rx M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InfuCare Rx

What does InfuCare Rx do?

InfuCare Rx is a nationwide specialty pharmacy infusion therapy services provider that delivers clinical infusion care to patients with complex and chronic conditions. Its core offerings span six therapy areas — anti-infective therapy, bleeding disorders, chronic inflammatory therapy, immunoglobulin (IVIG/SCIG) therapy, parenteral nutrition, and specialty injectables — administered through company-operated Centers of Excellence, infusion suites, and home-based infusion nursing. These clinical services are supported by InfuCare Rx Health®, a proprietary digital care management platform with patient portal, mobile app, digital prescriptions, and secure communication, alongside enrollment, benefit verification, prior authorization, and 24/7 clinical support services.

Is InfuCare Rx a public or private company?

InfuCare Rx is a private company. It is classified as venture growth investor backed and is currently operating.

When was InfuCare Rx founded?

InfuCare Rx was founded in 2014. It employs 251 to 500 people.

Where is InfuCare Rx based?

InfuCare Rx is headquartered in Fairfield, United States, in the North America region.

How does InfuCare Rx make money?

Two revenue lines are on record. Specialty Infusion Therapy Services are the primary driver. The others are clinical Therapy Management.

Who are InfuCare Rx's main competitors?

Direct peers on record are PromptCare, Amerita (formerly AmeritaRx), KabaFusion, Soleo Health, Coram CVS (CVS Health Infusion Services) and Option Care Health. Intramed Plus is listed as a regional player. PantherRx Rare is listed as an emerging player. Broad incumbents are Optum Specialty / OptumRx Infusion and Accredo (Express Scripts / Evernorth).

Does InfuCare Rx have an API?

No public API is recorded for InfuCare Rx.

What industry is InfuCare Rx in?

InfuCare Rx's product category is Specialty Infusion Therapy Services. Its primary akta.pro industry code is HLADAFAG, Home Infusion Therapy & IV Nursing Services, with a secondary code of HLAFALAG, Infusion & Home Infusion Pharmacy Services. Its NAICS code is 621610 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireInfuCare Rx® Completes Recapitalization with a New Strategic Capital PartnerInfuCare Rx announced it has completed a recapitalization through a strategic founder-led equity buyback, with Guggenheim Investments serving as the new strategic capital partner. The transaction returns the company to wholly founder-owned status under Deven Patel, following One Equity Partners' exit as a prior investor. InfuCare Rx, a specialty infusion therapy provider operating across all 50 states with approximately 14,000 patients and 800 employees, indicated this capital support will fuel continued growth in its three segments: Immunoglobulin Therapy, Specialty Infusion, and Bleeding Disorders.ThemiddlemarketOEP Exits InfuCare Rx in Founder-Led Equity BuybackOne Equity Partners has exited its investment in InfuCare Rx Inc. through a strategic founder-led equity buyback, concluding its value creation initiatives that began in early 2022. During its hold period, OEP supported InfuCare's operational scaling and acquisition strategy, including the purchase of Florida-based Health First Infusion to expand the company's brick-and-mortar footprint. InfuCare Rx, founded in 2014, is a privately held specialty infusion therapy provider serving over 14,000 patients across all 50 states through three segments: Immunoglobulin Therapy, Specialty Infusion, and Bleeding Disorders.InfucarerxHealth First Infusion Business Assets Acquired by InfuCare Rx, a Leading Home Infusion Therapy ProviderInfuCare Rx announced the acquisition of the business assets of Health First Infusion (HFI) on November 23, 2022, aiming to expand its home infusion services into Florida. This acquisition is part of InfuCare Rx's strategy to enhance its reach and accessibility to medically complex patients across the nation. The financial terms of the private transaction were not disclosed.ParagonventuresHealth First Infusion Business Assets Acquired by InfuCare RxInfuCare Rx has completed the acquisition of business assets from Health First Infusion, a home infusion pharmacy based in Florida. This transaction is part of InfuCare Rx's strategic plan to expand its operational footprint into new regions across the United States. Financial terms of the private deal were not disclosed.InfucarerxOne Equity Partners Completes Investment in InfuCare Rx, a Leading Home Infusion Therapy ProviderOne Equity Partners has completed a strategic investment in InfuCare Rx, a national provider of home infusion therapy services, focusing on complex conditions in the United States. The investment aims to support the company's growth and expand its regional presence as demand for home-based care increases, especially post-COVID. InfuCare Rx serves over 4,000 patients across 43 states and is aligned with a broader shift towards cost-effective, home-based healthcare delivery.PR NewswireOne Equity Partners Completes Investment in InfuCare Rx, a Leading Home Infusion Therapy ProviderOne Equity Partners completed a strategic investment in InfuCare Rx, a national provider of home infusion therapy services. The financial terms of the transaction were not disclosed, but the investment aims to accelerate InfuCare Rx's growth and expansion into new regions.